RecruitingNot ApplicableNCT06867874
Syncytiotrophoblast-derived Extracellular Vesicles in Placenta Previa and Accreta Spectrum
Shedding of Syncytiotrophoblast-derived Extracellular Vesicles is Increased in Placenta Previa and Accreta Spectrum: a Case-control Study.
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment
70 participants
Start Date
Jul 10, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The main goal of this case-control study is to quantify the levels of circulating syncytiotrophoblast-derived extracellular vesicles (STBEVs) in maternal blood in a population of women with placenta previa and placenta accreta spectrum.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria3
- Pregnant women with diagnosis of placenta previa and accreta spectrum (cases)
- Healthy pregnant women
- > 18 years
Exclusion Criteria5
- < 18 years
- Twin pregnancies
- Chronic Infections
- Cancers
- Unable to give the written consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREBlood sample
Blood sample
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06867874
Related Trials
Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta
NCT070259546 locations
Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders
NCT065121811 location
Association of Assisted Reproductive Technologies Parameters With the Perinatal Outcome
NCT069182366 locations
EXAMINATION OF SOME MOLECULES IN PLACENTAS OF PATIENTS WITH PLACENTA PREVIA, PLACENTA PERCREATA
NCT068493491 location
Placenta Accreta Spectrum Outcome After Uterine Conservation
NCT048668881 location